CHRONIC HEPATITIS D INFECTION
Clinical trials for CHRONIC HEPATITIS D INFECTION explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS D INFECTION trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS D INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Weekly shot challenges daily injection in fight against aggressive liver disease
Disease control Recruiting nowThis global Phase 3 trial is testing whether a new weekly injection called brelovitug (BJT-778) works as well as or better than the current daily injection (bulevirtide) for treating chronic hepatitis D, a serious liver infection. About 172 participants will be randomly assigned …
Matched conditions: CHRONIC HEPATITIS D INFECTION
Phase: PHASE3 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New shot offers hope against aggressive liver virus
Disease control Recruiting nowThis study is testing whether a new injectable drug called Brelovitug can safely control Hepatitis D infection, a serious liver disease. About 80 people with chronic Hepatitis D will receive either weekly or monthly injections for nearly two years, or start treatment after a 12-w…
Matched conditions: CHRONIC HEPATITIS D INFECTION
Phase: PHASE3 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC